rhodioloside has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Yao, W | 1 |
| Fu, B; Li, R; Yan, T; Zhang, X; Zhang, Y; Zhu, L | 1 |
| Cai, F; Chen, S; Gu, C; Mao, G; Wang, G; Wang, J; Yan, J; Yang, Z | 1 |
1 review(s) available for rhodioloside and Parkinson Disease
| Article | Year |
|---|---|
The Therapeutic Potential of Salidroside for Parkinson's Disease.
Topics: Animals; Glucosides; Parkinson Disease; Phosphatidylinositol 3-Kinases; Signal Transduction | 2023 |
2 other study(ies) available for rhodioloside and Parkinson Disease
| Article | Year |
|---|---|
Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis.
Topics: Animals; Disease Models, Animal; Glucosides; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinson Disease; Phenols; Pyroptosis; Signal Transduction | 2020 |
Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling.
Topics: alpha-Synuclein; Autophagy; Cell Line; Glucosides; Humans; Neuroprotective Agents; Parkinson Disease; Phenols; Point Mutation; Rhodiola; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |